Financials data is unavailable for this security.
View more
Year on year vTv Therapeutics Inc 's revenues fell -100.00% from 2.02m to 0.00. has fallen 5.67% from a loss of 19.16m to a larger loss of 20.25m.
Gross margin | -- |
---|---|
Net profit margin | -2,540.90% |
Operating margin | -2,705.70% |
Return on assets | -73.77% |
---|---|
Return on equity | -- |
Return on investment | -170.69% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at vTv Therapeutics Inc fell by 2.68m. Cash Flow from Financing totalled 12.00m or -- of revenues. In addition the company used 19.08m for operations while cash from investing totalled 4.40m.
Cash flow per share | -6.84 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 5.47 |
---|---|
Tangible book value per share | 5.47 |
More ▼
Balance sheet in USDView more
Current ratio | 6.61 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼